Filter posts

“Real Opportunity” to Boost Diversity in Biotech

The Biotechnology Innovation Organization has set a goal for its member companies to have 50% …

BIO at 25 – A View of the Past; a Glimpse into the Future

In recognition of BIO’s 25th anniversary, BIO CEO and President, Jim Greenwood sat down with …

FDA’s Historic Gene Therapy Approvals Could Be Beginning of the End of Blood Cancer

In his inaugural address this June as chairman of the world’s largest biotechnology industry group, …

Alnylam CEO John Maraganore Takes the Reins as BIO Chair

John Maraganore, CEO of Cambridge-based Alnylam Pharmaceuticals, begins his chairmanship of BIO this morning when …